DUBLIN--(BUSINESS WIRE)--The "North America Hormone Replacement Therapy Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The publisher expects the market to reach a value of US$ 4.7 Billion by 2024, registering a CAGR of 5.35% during 2019-2024.

The North America hormone replacement therapy market reached a value of US$ 3.5 Billion in 2018. Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. HRT is available in several forms such as gels, injections, implants, and skin and mouth patches (transdermal). However, it may not be suitable for patients that have a record of blood clots, liver disease and untreated high blood pressure.

North America hormone replacement therapy market is currently being driven by several factors. A surge in the incidences of hormone imbalance disorders, especially in the geriatric and neonatal populations, is spurring the demand for HRT in North America. In line with this, the rising need for new treatment options with better safety results is further catalyzing the market growth in the region. Apart from this, increasing R&D activities for hormone replacement products is enhancing their quality and efficiency. Additionally, the increasing consumer awareness, coupled with the rising technological innovations, such as new gel-based formulations, have also spurred the demand for hormone replacement products in the region.

Key Questions Answered in This Report:

Report Coverage:

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Hormone Replacement Therapy Market

5.1 Market Performance

5.2 Market Breakup by Product

5.3 Market Breakup by Route of Administration

5.4 Market Breakup by Type of Disease

5.5 Market Breakup by Region

5.6 Market Forecast

6 North America Hormone Replacement Therapy Market

6.1 Market Performance

6.2 Market Forecast

7 North America Hormone Replacement Therapy Market: Breakup by Product

7.1 Estrogen Replacement Therapy

7.2 Human Growth Hormone Replacement Therapy

7.3 Thyroid Replacement Therapy

7.4 Testosterone Replacement Therapy

7.5 Others

8 North America Hormone Replacement Therapy Market: Breakup by Route of Administration

8.1 Oral

8.2 Parenteral

8.3 Transdermal

9 North America Hormone Replacement Therapy Market: Breakup by Type of Disease

9.1 Menopause

9.2 Hypothyroidism

9.3 Male Hypogonadism

9.4 Growth Hormone Deficiency

9.5 Others

10 North America Hormone Replacement Therapy Market: Breakup by Country

10.1 United States

10.1.1 Historical market Trends

10.1.2 Market Breakup by Product

10.1.3 Market Breakup by Route of Administration

10.1.4 Market Breakup by Type of Disease

10.1.5 Market Forecast

10.2 Canada

10.3 Mexico

11 SWOT Analysis

11.1 Overview

11.2 Strengths

11.3 Weaknesses

11.4 Opportunities

11.5 Threats

12 Value Chain Analysis

12.1 Overview

12.2 Research and Development

12.3 Raw Material Procurement

12.4 Manufacturing

12.5 Marketing

12.6 Distribution

12.7 End-Use

13 Porter's Five Forces Analysis

13.1 Overview

13.2 Bargaining Power of Buyers

13.3 Bargaining Power of Suppliers

13.4 Degree of Rivalry

13.5 Threat of New Entrants

13.6 Threat of Substitutes

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/xr45u2

Here is the original post:
North America Hormone Replacement Therapy Market Expected to Generate a Value of US $4.7 Billion by 2024 - ResearchAndMarkets.com - Business Wire